New way for states to cover pricey gene therapies will start with sickle cell disease
The U.S. Food and Drug Administration late last year approved two breakthrough gene therapies for sickle cell disease patients. Now a new federal program seeks to make these life-changing treatments available to patients with low incomes ā and it could be a model to help states pay for other expensive therapies. The new sickle cell […]
The post New way for states to cover pricey gene therapies will start with sickle cell disease appeared first on Missouri Independent.